• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New research hopes to identify individuals at risk of clinically significant COPD

Bioengineer by Bioengineer
June 25, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New research from the University of Alabama at Birmingham provides evidence, for the first time, for physicians to continue using the spirometry criteria set by major respiratory societies for the diagnosis of airflow obstruction and chronic obstructive pulmonary disease.

Published in the Journal of the American Medical Association, Surya Bhatt, M.D., associate professor in the Division of Pulmonary, Allergy and Critical Care Medicine and medical director of the UAB Pulmonary Function and Exercise Physiology Lab, says there is much confusion and debate in the medical community on what are the best spirometry criteria to use for diagnosing COPD.

Currently, major respiratory society guidelines recommend diagnosing airflow obstruction when the ratio of the forced expiratory volume in one second (FEV1) to the forced vital capacity (FVC) is less than a fixed threshold of 0.70. This means that, during a forced exhalation following a maximal inhalation, a normal individual should be able to blow out at least 70 percent of their lung size or vital capacity in the first second. However, there is no rigorous, population-based evidence to support the threshold of 0.70, which was set by expert opinion as the optimal FEV1/FVC threshold for defining clinically significant airflow obstruction, according to the published research.

“A diagnosis of COPD needs confirmation by demonstrating obstruction to airflow using spirometry,” Bhatt said. “The currently used criteria are based on expert opinion, and until these results were published, there was not enough evidence to support their use.”

The multisite team, led by researchers from UAB and the University of Columbia, analyzed data from a large, multi-ethnic sample of 24,207 adults in the United States, and found that the currently used threshold of 0.70 provided discrimination of COPD-related hospitalization and mortality that was not significantly different from — or was more accurate than — other fixed thresholds. The 0.70 threshold was also more accurate than other thresholds that define normal lung function and are derived from reference populations. These results support the continued use of FEV1/FVC

Cigarette smoking is the primary cause of COPD in the United States, but air pollutants at home (secondhand smoke and some heating fuels), at work (dusts, gases and fumes) and for those with genetic predisposition also can cause COPD. COPD makes breathing difficult for the estimated 14 million Americans who have this disease. Millions more suffer from COPD, but have not been diagnosed. Although there is no cure, it can be treated.

“The ongoing disagreement between experts on the best spirometry criteria to diagnose airflow obstruction has resulted in a lack of clarity for clinicians,” Bhatt said. “Using a simple standard threshold has the potential to improve the diagnosis and treatment of this common disease.”

According to the Centers for Disease Control and Prevention, Alabama has one of the highest rates of COPD. About 9.6 percent of Alabama residents surveyed in 2011 reported having been told by a health care professional that they have COPD. “The symptoms of COPD are often non-specific, and an accurate diagnosis will determine who gets appropriately treated, and is also important for avoiding unnecessary therapies,” Bhatt said.

###

Media Contact
Adam Pope

[email protected]

Related Journal Article

https://www.uab.edu/news/health/item/10567-new-research-hopes-to-identify-individuals-at-risk-of-clinically-significant-copd
http://dx.doi.org/10.1001/jama.2019.7233

Tags: Internal MedicineMedicine/HealthPulmonary/Respiratory Medicine
Share12Tweet7Share2ShareShareShare1

Related Posts

Insufficient NNMT Disrupts Implantation via H3K9me3 Pathway

October 7, 2025

AI Diagnostic System Performance Evaluation in China

October 7, 2025

Leading Scientific Breakthroughs Honored at ACC Middle East Conference

October 7, 2025

Reelin: A Promising Protein for Gut Repair and Depression Treatment

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    920 shares
    Share 368 Tweet 230
  • New Study Reveals the Science Behind Exercise and Weight Loss

    99 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    94 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    77 shares
    Share 31 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Insufficient NNMT Disrupts Implantation via H3K9me3 Pathway

AI Diagnostic System Performance Evaluation in China

Brain-on-a-Chip Technology Uncovers Mechanisms of Brain Damage in Sepsis and Neurodegenerative Diseases

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.